Gastrointestinal Remedies: Digestive and Immunity Health - US - April 2010
US $4,395.00 (Excl.Tax)Excl. Tax Buy Now
The market for over the counter (OTC) gastrointestinal (GI) remedies performed strongly in 2009, driven by the shift of prescription brands to OTC availability. However, most brands are losing ground to private label competition, and there is question as to whether new launches will truly result in incremental sales. A new class of product threatens to take the focus away from occasional OTC remedies in favor of regular dietary supplements.
In this report, Mintel takes a look at the state of the GI remedy market and explains why certain brand strategies are working and others are not. Consumer behavior toward GI remedies is examined for ways to increase sales.
Analysis and insights offered in this report include:
This report will give you a complete 360-degree view of your market. Not only is it rooted in robust proprietary and high-quality third-party data, but our industry experts put that data into context and you’ll quickly understand:
What They Want. Why They Want It.
Who’s Winning. How To Stay Ahead.
Size, Segments, Shares And Forecasts: How It All Adds Up.
New Ideas. New Products. New Potential.
Where The White Space Is. How To Make It Yours.
What’s Shaping Demand – Today And Tomorrow.